Back to Search
Start Over
D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review
- Source :
- Thrombosis and Haemostasis, 110(2), 233-243. Georg Thieme Verlag
- Publication Year :
- 2013
-
Abstract
- SummaryPeripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2–4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43–3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
030204 cardiovascular system & hematology
Fibrin Fibrinogen Degradation Products
03 medical and health sciences
Peripheral Arterial Disease
0302 clinical medicine
Risk Factors
Internal medicine
D-dimer
medicine
Humans
fibrin degradation products
Prospective cohort study
business.industry
arterial thrombotic events
Thrombosis
Hematology
intermittent claudication
medicine.disease
Intermittent claudication
Confidence interval
Surgery
030104 developmental biology
Cardiovascular Diseases
Meta-analysis
Relative risk
Cohort
Cardiology
medicine.symptom
business
Biomarkers
Subjects
Details
- ISSN :
- 2567689X and 03406245
- Volume :
- 110
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Thrombosis and haemostasis
- Accession number :
- edsair.doi.dedup.....c32d5898493ae7b637b4a16a52567c32